ABP Pediatric Hematology-Oncology Certification Exam Practice Test
Build your confidence for ABP Pediatric Hematology-Oncology Certification Exam. Practice the concepts, understand the answers, and strengthen your knowledge one question at a time.
Try a sample questionExam overview and details
The American Board of Pediatrics (ABP) Pediatric Hematology-Oncology Certification Exam is the definitive credential validating a physician's expertise in the comprehensive care of children and adolescents with blood disorders and cancer. Achieving board certification signifies the successful completion of rigorous fellowship training and the mastery of a complex body of knowledge encompassing benign hematology, malignant diseases, stem cell transplantation, and the management of life-threatening oncologic emergencies. This certification is not merely an endpoint of training but a public commitment to maintaining the highest standards of clinical practice, evidence-based medicine, and ethical patient care. It distinguishes the diplomate as a specialist qualified to manage the full spectrum of pediatric hematologic-oncologic conditions, from common anemias and bleeding disorders to rare solid tumors and high-risk leukemias. In an evolving field marked by rapid therapeutic advances, certification underscores a physician's dedication to lifelong learning and proficiency in delivering sophisticated, multidisciplinary care that significantly impacts patient survival and quality of life.
Sample Questions
Choose an answer and explore the explanation to see how practice works.
A 6-year-old girl has microcytic anemia refractory to 6 months of observed oral iron. Hemoglobin is 8.8 g/dL, MCV 62 fL, ferritin is low-normal, transferrin saturation is 5%, CRP is normal, and hepcidin is inappropriately high for iron deficiency. Her brother had the same pattern. Which diagnosis is most likely?
A 10-year-old boy with Ewing sarcoma of T8 develops new back pain, bilateral leg weakness, hyperreflexia, and urinary hesitancy over 12 hours. MRI is available in 30 minutes. Which action should occur now?
A term newborn has diffuse petechiae and platelets of 9,000/uL shortly after birth. The mother is healthy with normal platelet count and no autoimmune disease. Cranial ultrasound shows a small intraventricular hemorrhage. Platelet antigen testing shows the infant inherited paternal HPA-1a, and maternal antibody is present. What is the best immediate platelet support?
A 9-year-old boy has frequent epistaxis, dental bleeding, and a family history of mild bleeding in both sexes. VWF antigen is 38 IU/dL, VWF activity is 34 IU/dL, factor VIII is 46 IU/dL, and multimers are normal. He needs a dental extraction. Which preprocedure plan is most appropriate if a prior challenge shows an adequate response?
A 14-year-old girl presents with gingival bleeding, fever, WBC 18,000/uL, platelets 14,000/uL, fibrinogen 90 mg/dL, and PT/PTT prolongation. Smear shows abnormal promyelocytes with bundles of Auer rods. Cytogenetics are pending. Which initial action should occur as soon as acute promyelocytic leukemia is suspected?
Exam insights and study advice
Board certification in Pediatric Hematology-Oncology is a critical differentiator for career advancement and professional credibility. It is a mandatory requirement for academic appointments, leadership roles in major pediatric cancer centers, and principal investigator status on cooperative group clinical trials. Hospitals and healthcare systems prioritize board-certified specialists for credentialing and privileging, recognizing the certification as a benchmark of competency and a safeguard for patient safety. For the individual physician, it confers industry-wide recognition as an expert, enhances patient and peer trust, and is often linked to increased professional opportunities and compensation. Ultimately, this certification matters because it formally attests to the specialized knowledge required to navigate the complexities of childhood cancer and blood disorders, ensuring the highest standard of care for a vulnerable patient population.
What this exam covers
Use the published domain weights to plan your study. Practice results do not predict your certification exam score.
01Solid Tumors
This domain addresses solid tumors occurring frequently in pediatric populations. Candidates study diagnosis methods, clinical staging procedures, and therapeutic approaches for various childhood solid neoplasms and related cancers.
02General Oncology Issues
This domain focuses on general oncology issues encountered in pediatric patients. Candidates review supportive care principles, late effects of treatment protocols, and acute oncologic emergencies requiring rapid medical responses.
03Erythrocytes
This domain focuses intensely on erythrocytes, covering red blood cell production, destruction, and related disorders. Candidates review clinical presentations and diagnostic criteria for various pediatric anemias within this category.
04Hematologic Malignancies
This section covers hematologic malignancies such as leukemia and lymphoma. Review includes disease pathophysiology, classification systems, and modern treatment protocols designed specifically for pediatric patients undergoing targeted therapy programs.
05Hemostasis/Thrombosis
This specific section addresses hemostasis and thrombosis in pediatric hematology practice. Candidates examine specific coagulation pathways, bleeding disorders, and thrombotic events requiring clinical intervention and ongoing patient management strategies.
06Hematopoietic Stem-Cell Transplant (HSCT)
This vital section focuses on hematopoietic stem-cell transplantation procedures for children. Review includes crucial conditioning regimens, strict donor selection criteria, and the thorough management of transplant-related complications in pediatric hematology-oncology patients.
07Platelets
This domain examines platelets and associated disorders affecting pediatric patients. Review covers normal platelet function, production rates, and quantitative or qualitative platelet abnormalities requiring medical attention and diagnostic evaluation.
08Bone Marrow Failure
This domain covers bone marrow failure syndromes occurring in children. Study topics include congenital and acquired conditions affecting bone marrow production, cellular output, and related hematologic parameters during clinical assessments.
09Core Knowledge in Scholarly Activities
This domain covers core knowledge in scholarly activities for pediatric hematology-oncology specialists. Candidates examine research methods, study design principles, and data interpretation techniques relevant to clinical investigation in this field.
10Transfusion Medicine
This extensive section examines transfusion medicine practices relevant to pediatric patient care. Topics include blood product administration, transfusion reactions, and component therapy management protocols used extensively in hospital settings during treatments.
11Leukocytes
This section covers leukocytes and white blood cell disorders encountered frequently in pediatric populations. Candidates study normal leukocyte development alongside pathological conditions affecting white blood cells during clinical practice.